Molecular dynamics simulations confirmed the structural stability of the peptide–ACE complexes, while network pharmacology analysis identified several hypertension-related targets, particularly those associated with the renin–angiotensin–aldosterone system (RAAS), underscoring the peptides’ broader therapeutic potential. This evidence concerns the gene ACE and hypertensive disorder.